Using Pharmacokinetic/efficacy Modeling to Identify the Optimal Schedule for MLN0264, an Anti- Guanylyl Cyclase C (GCC) Antibody-Drug Conjugate, in a Range of Xenograft Models
CANCER RESEARCH（2014）
关键词
Antibody Pharmacokinetics
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要